Peptide bioregulatorEvidence: Russian preclinicalRUO · not approved
Research Use Only. Not an approved medicine and not for human use. Educational only — no dosing or medical advice.
What it is
Bronchogen is a short synthetic "peptide bioregulator" (Khavinson-type) marketed toward respiratory/lung tissue.
Proposed mechanism
These very short peptides are hypothesized in Russian research to bind DNA and tissue-selectively influence gene expression ("peptide bioregulation").1 The mechanism is not independently established.
State of the evidence
Primarily Russian preclinical work; little independent human data; no approval.
Regulatory & status
Not approved; RUO.
Reconstitution (reference only)
Lab-handling reference only — not a preparation or dosing instruction: 3 mL (300 units) reconstitution solution per 20 mg vial. See the reconstitution calculator for the arithmetic. This page does not provide dosing guidance.
For educational and research purposes only. This content is not medical advice. Compounds referenced are research use only and not intended to diagnose, treat, cure, or prevent any disease. Free Peptide University does not sell compounds.